During the Neogene period, our ancestors produced a useful enzyme that lowered uric acid levels. Gene-editing is reviving ...

One day you wake up feeling fine, and the next day you suddenly can't even walk. For most people, the pain is unbearable and ...

The pain of gout has been with us for millennia at least, but scientists have gone back much further in time – more than 20 ...

Researchers used evolutionary genetics and CRISPR gene editing tech to develop an innovative treatment for gout. The approach ...

Gout could be treated by an ancient gene that humans lost millions of years ago, suggests new research. A form of arthritis ...

Scientists used CRISPR to reactivate uricase, an enzyme humans lost millions of years ago. Restoring the gene in liver cells lowered uric acid and blocked fat buildup, pointing to a potential therapy ...

Scientists at Georgia State University have revived a 20-million-year-old gene called uricase, which may offer new hope in ...

Sobi® (STO: SOBI), a global biopharmaceutical company dedicated to delivering innovative treatments for patients with rare diseases, today announced that the U.S. Food and Drug Administration (FDA) ...

Investors, analysts, and members of the media are invited to a conference call on Tuesday, 16 September, at 16:30 CEST, 15:30 BST, and 10:30 EDT. The call will present insights from management and Dr.

The latest announcement is out from XORTX Therapeutics Inc ( ($TSE:XRTX) ). XORTX Therapeutics Inc. has initiated the preparation of an ...

Clinical efforts to get patients with a history of gout to reach specific target serum urate (SU) levels less than either 5 or 6 mg/dL could prevent the great majority of gout flares and ...